PDF herunterladen
Semin Reprod Med 2019; 37(03): 119-124
DOI: 10.1055/s-0039-3400240
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Clinical Translational Studies of Kisspeptin and Neurokinin B

Tia Hunjan
1   Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, United Kingdom
,
Ali Abbara
1   Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, United Kingdom
› Institutsangaben Funding The Section of Endocrinology and Investigative Medicine is funded by grants from the MRC, BBSRC, and NIHR and is supported by the NIHR Biomedical Research Centre Funding Scheme. T.H. is supported by an Imperial Health Charity Research Fellowship and NIHR Research Professorship awarded to Professor Waljit S. Dhillo. A.A. is supported by National Institute of Health Research (NIHR) Clinician Scientist Award.
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Dezember 2019 (online)

   Lizenzen und Reprints

Abstract

Kisspeptin and neurokinin B (NKB) are hypothalamic neuropeptides that are vital for reproductive health. An absence of either kisspeptin or NKB signaling results in hypogonadotrophic hypogonadism and a failure to proceed through puberty. In recent years, several studies have demonstrated potential avenues for the clinical utility of medications that act through these pathways in the assessment and treatment of reproductive disorders. Kisspeptin acts to stimulate hypothalamic gonadotrophic-releasing hormone (GnRH) secretion from the hypothalamus. Kisspeptin induces gonadotrophin secretion in both healthy men and women, and in women with reproductive disorders such as hypothalamic amenorrhea (HA). Kisspeptin-based treatments hold promise for use during in vitro fertilization (IVF) treatment; a bolus of kisspeptin-54 induces an LH surge of 12 to 14 hours of duration sufficient to induce oocyte maturation, but with markedly reduced rates of the most significant complication of IVF treatment, ovarian hyperstimulation syndrome (OHSS). Kisspeptin could also be used chronically to restore reproductive health in patients with functional hypogonadism, such as those with HA. Furthermore, kisspeptin has potential as a diagnostic test of hypothalamic function; a “kisspeptin test” could be used in children with delayed puberty to identify the subset with genetically determined deficits in hypothalamic pathways (congenital hypogonadotrophic hypogonadism [CHH]). In addition to its role in hypothalamic GnRH pulse generation, NKB plays a critical role in the occurrence of one of the most troubling symptoms of the menopause, the “hot flush.” Neurokinin-3 receptor (NK3R) antagonists are highly effective as treatments for hot flushes in postmenopausal women, with several compounds now in late-phase development. Furthermore, NK3R antagonism leads to a reduction in LH secretion by reducing GnRH pulsatility in the hypothalamus and has been shown to reduce androgen levels in women with polycystic ovary syndrome (PCOS) (in whom GnRH pulsatility is often increased). In summary, although further detailed evaluation in several clinical settings is ongoing, medications based on kisspeptin and NKB pathways have prodigious potential in the assessment and treatment of reproductive disorders.

Keywords

Kisspeptin - neurokinin B - reproductive disorders
 

  • References

  • 1 de Roux N, Genin E, Carel J-C, Matsuda F, Chaussain J-L, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003; 100 (19) 10972-10976
    CrossrefPubMedGoogle Scholar
  • 2 Seminara SB, Messager S, Chatzidaki EE. , et al. The GPR54 gene as a regulator of puberty. Obstet Gynecol Surv 2004; 59 (05) 351-353
    CrossrefPubMedGoogle Scholar
  • 3 Topalglu AK, Tello JA, Kotan LD. , et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. Obstet Gynecol Surv 2012; 67 (06) 352-353
    CrossrefPubMedGoogle Scholar
  • 4 Teles MG, Bianco SDC, Brito VN. , et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008; 358 (07) 709-715
    CrossrefPubMedGoogle Scholar
  • 5 Taniguchi Y, Kuwahara A, Tachibana A. , et al. Intra-follicular kisspeptin levels are related to oocyte maturation and gonadal hormones in patients who are undergoing assisted reproductive technology. Reprod Med Biol 2017; 16 (04) 380-385
    CrossrefPubMedGoogle Scholar
  • 6 Guran T, Tolhurst G, Bereket A. , et al. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. J Clin Endocrinol Metab 2009; 94 (10) 3633-3639
    CrossrefPubMedGoogle Scholar
  • 7 Gianetti E, Tusset C, Noel SD. , et al. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab 2010; 95 (06) 2857-2867
    CrossrefPubMedGoogle Scholar
  • 8 Young J, Bouligand J, Francou B. , et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab 2010; 95 (05) 2287-2295
    CrossrefPubMedGoogle Scholar
  • 9 Francou B, Bouligand J, Voican A. , et al. Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations. PLoS One 2011; 6 (10) e25614
    CrossrefPubMedGoogle Scholar
  • 10 Young J, George JT, Tello JA. , et al. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology 2013; 97 (02) 193-202
    CrossrefPubMedGoogle Scholar
  • 11 Lippincott MF, León S, Chan Y-M. , et al. Hypothalamic reproductive endocrine pulse generator activity independent of neurokinin B and dynorphin signaling. J Clin Endocrinol Metab 2019; 104 (10) 4304-4318
    CrossrefPubMedGoogle Scholar
  • 12 Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun 2004; 320 (02) 383-388
    CrossrefPubMedGoogle Scholar
  • 13 Messager S, Chatzidaki EE, Ma D. , et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci U S A 2005; 102 (05) 1761-1766
    CrossrefPubMedGoogle Scholar
  • 14 Dhillo WS, Chaudhri OB, Patterson M. , et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005; 90 (12) 6609-6615
    CrossrefPubMedGoogle Scholar
  • 15 Dhillo WS, Chaudhri OB, Thompson EL. , et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab 2007; 92 (10) 3958-3966
    CrossrefPubMedGoogle Scholar
  • 16 Chan YM, Butler JP, Sidhoum VF, Pinnell NE, Seminara SB. Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle. J Clin Endocrinol Metab 2012; 97 (08) E1458-E1467
    CrossrefPubMedGoogle Scholar
  • 17 Jayasena CN, Comninos AN, Veldhuis JD. , et al. A single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy women. Clin Endocrinol (Oxf) 2013; 79 (04) 558-563
    CrossrefPubMedGoogle Scholar
  • 18 Chan YM, Butler JP, Pinnell NE. , et al. Kisspeptin resets the hypothalamic GnRH clock in men. J Clin Endocrinol Metab 2011; 96 (06) E908-E915
    CrossrefPubMedGoogle Scholar
  • 19 George JT, Veldhuis JD, Roseweir AK. , et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab 2011; 96 (08) E1228-E1236
    CrossrefPubMedGoogle Scholar
  • 20 George JT, Veldhuis JD, Tena-Sempere M, Millar RP, Anderson RA. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clin Endocrinol (Oxf) 2013; 79 (01) 100-104
    CrossrefPubMedGoogle Scholar
  • 21 Abbara A, Narayanaswamy S, Izzi-Engbeaya C. , et al. Hypothalamic response to kisspeptin-54 and pituitary response to gonadotropin-releasing hormone are preserved in healthy older men. Neuroendocrinology 2018; 106 (04) 401-410
    CrossrefPubMedGoogle Scholar
  • 22 Gordon CM, Ackerman KE, Berga SL. , et al. Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017; 102 (05) 1413-1439
    CrossrefPubMedGoogle Scholar
  • 23 Jayasena CN, Nijher GMK, Chaudhri OB. , et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab 2009; 94 (11) 4315-4323
    CrossrefPubMedGoogle Scholar
  • 24 Castellano JM, Navarro VM, Fernández-Fernández R. , et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 2005; 146 (09) 3917-3925
    CrossrefPubMedGoogle Scholar
  • 25 Jayasena CN, Nijher GMK, Abbara A. , et al. Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea. Clin Pharmacol Ther 2010; 88 (06) 840-847
    PubMedGoogle Scholar
  • 26 Jayasena CN, Abbara A, Veldhuis JD. , et al. Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54. J Clin Endocrinol Metab 2014; 99 (06) E953-E961
    CrossrefPubMedGoogle Scholar
  • 27 Kinoshita M, Tsukamura H, Adachi S. , et al. Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats. Endocrinology 2005; 146 (10) 4431-4436
    CrossrefPubMedGoogle Scholar
  • 28 Jayasena CN, Abbara A, Comninos AN. , et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest 2014; 124 (08) 3667-3677
    CrossrefPubMedGoogle Scholar
  • 29 Abbara A, Jayasena CN, Christopoulos G. , et al. Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocrinol Metab 2015; 100 (09) 3322-3331
    CrossrefPubMedGoogle Scholar
  • 30 Abbara A, Clarke SA, Dhillo WS. Novel concepts for inducing final oocyte maturation in in vitro fertilization treatment. Endocr Rev 2018; 39 (05) 593-628
    CrossrefPubMedGoogle Scholar
  • 31 Abbara A, Islam R, Clarke SA. , et al. Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment. Clin Endocrinol (Oxf) 2018; 88 (06) 920-927
    CrossrefPubMedGoogle Scholar
  • 32 Zhai AJ, Liu J, Zhao H. Kisspeptin-10 (Kp-10) inhibits ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) secretion. Reproduction 2017; 154 (04) 355-362
    CrossrefPubMedGoogle Scholar
  • 33 Abbara A, Clarke S, Islam R. , et al. A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial. Hum Reprod 2017; 32 (09) 1915-1924
    CrossrefPubMedGoogle Scholar
  • 34 Castellano JM, Gaytan M, Roa J. , et al. Expression of KiSS-1 in rat ovary: putative local regulator of ovulation?. Endocrinology 2006; 147 (10) 4852-4862
    CrossrefPubMedGoogle Scholar
  • 35 Byri P, Gangineni A, Reddy KR, Raghavender KBP. Effect of kisspeptin on in vitro maturation of sheep oocytes. Vet World 2017; 10 (03) 276-280
    CrossrefPubMedGoogle Scholar
  • 36 Saadeldin IM, Koo OJ, Kang JT. , et al. Paradoxical effects of kisspeptin: it enhances oocyte in vitro maturation but has an adverse impact on hatched blastocysts during in vitro culture. Reprod Fertil Dev 2012; 24 (05) 656-668
    CrossrefPubMedGoogle Scholar
  • 37 Abbara A, Vuong LN, Ho VNA. , et al. Follicle size on day of trigger most likely to yield a mature oocyte. Front Endocrinol (Lausanne) 2018; 9: 193
    CrossrefPubMedGoogle Scholar
  • 38 Owens LA, Abbara A, Lerner A. , et al. The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function. Hum Reprod 2018; 33 (02) 292-302
    CrossrefPubMedGoogle Scholar
  • 39 Chan YM, Lippincott MF, Butler JP. , et al. Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2014; 99 (12) E2762-E2771
    CrossrefPubMedGoogle Scholar
  • 40 Lippincott MF, Chan YM, Delaney A, Rivera-Morales D, Butler JP, Seminara SB. Kisspeptin responsiveness signals emergence of reproductive endocrine activity: implications for human puberty. J Clin Endocrinol Metab 2016; 101 (08) 3061-3069
    CrossrefPubMedGoogle Scholar
  • 41 Chan YM, Lippincott MF, Kusa TO, Seminara SB. Divergent responses to kisspeptin in children with delayed puberty. JCI Insight 2018; 3 (08) 99109
    CrossrefPubMedGoogle Scholar
  • 42 Millar RP, Sonigo C, Anderson RA. , et al. Hypothalamic-pituitary-ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea. J Endocr Soc 2017; 1 (11) 1362-1371
    CrossrefPubMedGoogle Scholar
  • 43 Ramaswamy S, Seminara SB, Ali B, Ciofi P, Amin NA, Plant TM. Neurokinin B stimulates GnRH release in the male monkey (Macaca mulatta) and is colocalized with kisspeptin in the arcuate nucleus. Endocrinology 2010; 151 (09) 4494-4503
    CrossrefPubMedGoogle Scholar
  • 44 Jayasena CN, Comninos AN, De Silva A. , et al. Effects of neurokinin B administration on reproductive hormone secretion in healthy men and women. J Clin Endocrinol Metab 2014; 99 (01) E19-E27
    CrossrefPubMedGoogle Scholar
  • 45 Jayasena CN, Comninos AN, Stefanopoulou E. , et al. Neurokinin B administration induces hot flushes in women. Sci Rep 2015; 5: 8466
    CrossrefPubMedGoogle Scholar
  • 46 Prague JK, Roberts RE, Comninos AN. , et al. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389 (10081): 1809-1820
    CrossrefPubMedGoogle Scholar
  • 47 Teede HJ, Misso ML, Costello MF. , et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110 (03) 364-379
    CrossrefPubMedGoogle Scholar
  • 48 George JT, Kakkar R, Marshall J. , et al. Neurokinin B receptor antagonism in women with polycystic ovary syndrome: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 2016; 101 (11) 4313-4321
    CrossrefPubMedGoogle Scholar
  • 49 Clarke S, Abbara A, Eng PC. , et al. A single subcutaneous injection of the kisspeptin analogue, MVT-602, induces a more prolonged LH surge compared with kisspeptin-54 in healthy women. J Endocr Soc 2019; 3 (Suppl. 01) OR33-4
    CrossrefPubMedGoogle Scholar
  • 50 MacLean DB, Matsui H, Suri A, Neuwirth R, Colombel M. Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. J Clin Endocrinol Metab 2014; 99 (08) E1445-E1453
    CrossrefPubMedGoogle Scholar
  • 51 Nishizawa N, Takatsu Y, Kumano S. , et al. Design and synthesis of an investigational nonapeptide KISS1 receptor (KISS1R) agonist, Ac-d-Tyr-hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2 (TAK-448), with highly potent testosterone-suppressive activity and excellent water solubility. J Med Chem 2016; 59 (19) 8804-8811
    CrossrefPubMedGoogle Scholar
  • 52 Nishizawa N, Asami T, Nishibori K. , et al. A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. Bioorg Med Chem Lett 2019; 29 (04) 654-658
    CrossrefPubMedGoogle Scholar
  • 53 Decourt C, Robert V, Anger K. , et al. A synthetic kisspeptin analog that triggers ovulation and advances puberty. Sci Rep 2016; 6 (01) 26908
    CrossrefPubMedGoogle Scholar
  • 54 Decourt C, Robert V, Lomet D. , et al. The kisspeptin analog C6 is a possible alternative to PMSG (pregnant mare serum gonadotropin) for triggering synchronized and fertile ovulations in the Alpine goat. PLoS One 2019; 14 (03) e0214424
    CrossrefPubMedGoogle Scholar